Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy
dc.contributor.author | Ye, Ping | |
dc.contributor.author | Kourtis, Athena P. | |
dc.contributor.author | Kirschner, Denise E. | |
dc.date.accessioned | 2011-03-29T20:08:45Z | |
dc.date.accessioned | 2011-03-29T20:08:45Z | |
dc.date.available | 2011-03-29T20:08:45Z | en_US |
dc.date.issued | 2002-10-28 | |
dc.identifier.citation | Clinical Immunology 106 (2003) 95–105 <http://hdl.handle.net/2027.42/83364> | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/83364 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed?term=12672400 | |
dc.description.abstract | The extent to which highly active antiretroviral therapy can restore thymic function in HIV-1 infected patients is not known. We simulate treatment using a temporal model of thymopoiesis during HIV-1 infection, tracking thymic function by the number of recent thymic emigrants (RTE) exported to the periphery per day. Our results suggest that suppressing viral load in peripheral blood and improving inherent thymic function are necessary for the reconstitution of RTE levels in adult thymic infection with either R5 or X4 HIV-1 trains. This is also the case in pediatric thymic infection with R5 strains. However, recovery of RTE levels during pediatric infection with X4 strains also depends on high drug efficacy within the thymus. We further predict that protease inhibitors have high levels of efficacy directly suppressing viral replication within the thymus, while reverse transcriptase inhibitors have low efficacy. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier Science (USA) | en_US |
dc.subject | Thymus | en_US |
dc.subject | HAART | en_US |
dc.subject | Immune Reconstitution | en_US |
dc.subject | Pediatric Infection | en_US |
dc.subject | Mathematical Model | en_US |
dc.title | Reconstitution of thymic function in HIV-1 patients treated with highly active antiretroviral therapy | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Microbiology and Immunology, Department of | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 12672400 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/83364/1/Ye.CI2003.pdf | |
dc.identifier.doi | 10.1016/S1521-6616(02)00024-4 | |
dc.identifier.source | Clinical Immunology | en_US |
dc.owningcollname | Microbiology and Immunology, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.